FHTX
Price
$4.44
Change
+$0.15 (+3.50%)
Updated
Dec 3 closing price
Capitalization
250.52M
91 days until earnings call
Intraday BUY SELL Signals
MGNX
Price
$1.40
Change
-$0.02 (-1.41%)
Updated
Dec 3 closing price
Capitalization
88.56M
77 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FHTX vs MGNX

Header iconFHTX vs MGNX Comparison
Open Charts FHTX vs MGNXBanner chart's image
Foghorn Therapeutics
Price$4.44
Change+$0.15 (+3.50%)
Volume$156.21K
Capitalization250.52M
MacroGenics
Price$1.40
Change-$0.02 (-1.41%)
Volume$2.13M
Capitalization88.56M
FHTX vs MGNX Comparison Chart in %
FHTX
Daily Signal:
Gain/Loss:
MGNX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
FHTX vs. MGNX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHTX is a StrongBuy and MGNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (FHTX: $4.29 vs. MGNX: $1.43)
Brand notoriety: FHTX and MGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FHTX: 21% vs. MGNX: 41%
Market capitalization -- FHTX: $250.52M vs. MGNX: $88.56M
FHTX [@Biotechnology] is valued at $250.52M. MGNX’s [@Biotechnology] market capitalization is $88.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FHTX’s FA Score shows that 0 FA rating(s) are green whileMGNX’s FA Score has 0 green FA rating(s).

  • FHTX’s FA Score: 0 green, 5 red.
  • MGNX’s FA Score: 0 green, 5 red.
According to our system of comparison, both FHTX and MGNX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FHTX’s TA Score shows that 7 TA indicator(s) are bullish while MGNX’s TA Score has 4 bullish TA indicator(s).

  • FHTX’s TA Score: 7 bullish, 3 bearish.
  • MGNX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, FHTX is a better buy in the short-term than MGNX.

Price Growth

FHTX (@Biotechnology) experienced а -9.11% price change this week, while MGNX (@Biotechnology) price change was -1.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

FHTX is expected to report earnings on Mar 05, 2026.

MGNX is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FHTX($251M) has a higher market cap than MGNX($88.6M). FHTX YTD gains are higher at: -9.110 vs. MGNX (-56.003). MGNX has higher annual earnings (EBITDA): -26.91M vs. FHTX (-88.7M). FHTX has more cash in the bank: 199M vs. MGNX (176M). FHTX has less debt than MGNX: FHTX (23.7M) vs MGNX (37.2M). MGNX has higher revenues than FHTX: MGNX (164M) vs FHTX (24.2M).
FHTXMGNXFHTX / MGNX
Capitalization251M88.6M283%
EBITDA-88.7M-26.91M330%
Gain YTD-9.110-56.00316%
P/E RatioN/AN/A-
Revenue24.2M164M15%
Total Cash199M176M113%
Total Debt23.7M37.2M64%
FUNDAMENTALS RATINGS
MGNX: Fundamental Ratings
MGNX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FHTXMGNX
RSI
ODDS (%)
N/A
Bullish Trend 7 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
88%
Bullish Trend 7 days ago
82%
Momentum
ODDS (%)
Bullish Trend 7 days ago
86%
Bearish Trend 7 days ago
90%
MACD
ODDS (%)
Bullish Trend 7 days ago
90%
Bullish Trend 7 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
88%
Bullish Trend 7 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
84%
Bearish Trend 7 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
86%
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 15 days ago
88%
Bearish Trend 15 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 7 days ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
FHTX
Daily Signal:
Gain/Loss:
MGNX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MITI0.09N/A
N/A
MITESCO, INC.
SOHVY6.60N/A
N/A
Sumitomo Heavy Industries Co.
AVAI0.28N/A
N/A
Avant Technologies Inc.
BOIVF5.53N/A
N/A
Bollore Investissement
CNDCF9.86N/A
N/A
Canadian Banc Corp

FHTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FHTX has been loosely correlated with OCUL. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if FHTX jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FHTX
1D Price
Change %
FHTX100%
-2.50%
OCUL - FHTX
45%
Loosely correlated
-3.93%
ERAS - FHTX
44%
Loosely correlated
-3.50%
IPSC - FHTX
41%
Loosely correlated
-2.62%
MGNX - FHTX
41%
Loosely correlated
-2.06%
XNCR - FHTX
40%
Loosely correlated
-3.15%
More

MGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGNX has been loosely correlated with RGNX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if MGNX jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGNX
1D Price
Change %
MGNX100%
-2.06%
RGNX - MGNX
53%
Loosely correlated
-3.10%
CRBU - MGNX
50%
Loosely correlated
-0.56%
IDYA - MGNX
49%
Loosely correlated
-1.75%
BEAM - MGNX
49%
Loosely correlated
-2.83%
XNCR - MGNX
48%
Loosely correlated
-3.15%
More